Photobiomodulation at 660 nm Stimulates Fibroblast Differentiation
Mokoena DR, Houreld NN, Dhilip Kumar SS, Abrahamse H
Lasers in surgery and medicine · 41 citas
Etiquetas de revisión
Solo mecanismosDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Estudio in vitro o de mecanismos (clasificado por nuestro filtro de IA)
- Estudiado en
- Células o muestras de laboratorio
- Resultado principal
- Solo mecanismos
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- National Research Foundation
- Universidad u hospital
- University of Johannesburg
- Subvenciones
- National Research Foundation (112114); University of Johannesburg (020930)
Según 2 financiadores declarados.
Publicación
- Publicado
- 2019-12-09 · Lasers Surg Med · vol. 52 · número 7 · págs. 671–681
- Editorial
- Wiley
- Citado
- 51 citas · más que el 93% de estudios similares · 3.6× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 37 trabajos
- Acceso
- De pago
- Áreas de investigación
- Laser Applications in Dentistry and Medicine · Wound Healing and Treatments · Medical and Biological Ozone Research
- Palabras clave
- Fibroblast, Chemistry, Cell biology, Biology, Biochemistry, In vitro
- MeSH
- cells, cultured, fibroblasts, humans, wound healing, cell differentiation, cell survival, myofibroblasts
4 autores
- Dimakatso R. Mokoena🇿🇦University of Johannesburg
- Nicolette N. Houreld🇿🇦 · autor de correspondenciaUniversity of Johannesburg
- Sathish Sundar Dhilip Kumar🇿🇦University of Johannesburg
- Heidi Abrahamse🇿🇦University of Johannesburg
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background and objectives
Among many of the different complications that diabetic patients suffer, foot ulcers are the most challenging, and in many cases result in non-traumatic lower limb amputation and permanent disability. To alleviate this burden, new interventions such as photobiomodulation (PBM) have been utilized. However, the cellular pathways affected by PBM have not yet been fully recognized. The differentiation of fibroblasts into myofibroblasts forms a vital part of wound healing and is often impaired under diabetic conditions. Therefore, this study sought to investigate the effects of PBM at 660 nm on the transforming growth factor-β1 (TGF-β1)/Smad pathway and the differentiation of fibroblasts into myofibroblasts.
Study design/materials and methods
WS1 fibroblasts were treated with PBM using a wavelength of 660 nm at a fluence of 5 J/cm2 in normal, normal wounded, diabetic, and diabetic wounded models. Post-irradiation cellular responses were observed at 24, 48, and 72 hours to ascertain morphological changes and cell viability, and the expression of fibroblast differentiation markers (Thy-1 or CD90, extra domain A fibronectin or EDA-FN and α-smooth muscle actin or α-SMA), TGF-β1, phosphorylated (p)TGF-β receptor 1 (R1), and p-Smad2/3.
Results
There was a significant increase in cell viability in all irradiated cell models, and no real significant changes in TGF-β1, pTGF-β1R1, and p-Smad2/3. As incubation time post-irradiation increased, Thy-1 (CD90) decreased, while EDA-FN and α-SMA increased in wounded models.
Conclusions
PBM at 660 nm with 5 J/cm2 was successful in stimulating the differentiation of fibroblasts into myofibroblasts in diabetic wounded cells, which was independent of the TGF-β1/Smad pathway. Fibroblast transition into myofibroblasts is vital to wound healing, failure of which results in impaired healing; PBM is able to foster such a transition. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.